Expand OKUR Menu
OKUR MENU

Onkure Therapeutics - Class A (OKUR) closed at $2.58 on November 17, 2026, down 6.2% from the previous close, on volume of 222,293 shares (30-day average 392,062).

Key numbers
  • Last close: $2.58 (November 17, 2026)
  • 52-week range: $2.01 to $5.38
  • Market value: $106.3 million

Data as of November 17, 2026.

OKUR Stock Summary and Trading Ideas (Onkure Therapeutics - Class A | NASDAQ:OKUR)

Charts for Today's Stock Price and Implied Volatility in Onkure Therapeutics - Class A

17-Nov-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for OKUR by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Onkure Therapeutics - Class A (OKUR) Frequently Asked Questions

What does Onkure Therapeutics - Class A do?

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Ka. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.

What symbol and exchange does Onkure Therapeutics - Class A shares trade?

Onkure Therapeutics - Class A trades on the NASDAQ stock market under the symbol OKUR.

What is Onkure Therapeutics - Class A stock price doing today?

As of November 17, 2026, OKUR stock price declined to $2.58 with 222,293 million shares trading.

What is Onkure Therapeutics - Class A's Beta?

OKUR has a beta of 0.65, meaning it tends to be less sensitive to market movements. OKUR has a correlation of 0.01 to the broad based SPY ETF.

How much is Onkure Therapeutics - Class A worth?

OKUR has a market cap of $106.27 million. This is considered a Micro Cap stock.

How much money does Onkure Therapeutics - Class A make?

Last quarter Onkure Therapeutics - Class A reported $0 in Revenue and -$.36 earnings per share. This fell short of revenue expectation by $-200,000 and exceeded earnings estimates by $.03.

What are the top ETFs holding Onkure Therapeutics - Class A?

The top ETF exchange traded funds that OKUR belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.

Is Onkure Therapeutics - Class A (OKUR) a good investment?

OKUR has underperformed the market in the last year with a return of -17.6%, while the SPY ETF gained +10.1%. In the last 3 month period, OKUR fell short of the market, returning -35.3%, while SPY returned -5.4%. However, in the most recent 2 weeks OKUR has outperformed the stock market by returning -0.4%, while SPY returned -2.6%.

What are the support and resistance levels for Onkure Therapeutics - Class A (OKUR)?

OKUR support price is $2.54 and resistance is $2.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OKUR shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes